Search research articles
Contact Us
Filters
Showing results (41-50 of 146) with videos related to
Page
of 15
Sort By:
Respiratory Research
|
April 8, 2015
Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy
Gillian Stynes, Henrik Svedsater, Jaro Wex, et al.
Asthma Research and Practice
|
December 15, 2016
Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy
Henrik Svedsater, Gillian Stynes, Jaro Wex, et al.
Plos One
|
December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
Donald A Berry, Scott Berry, Peter Hale, et al.
BMC Cancer
|
June 30, 2007
External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer
Christopher M Booth, George Dranitsaris, M Corona Gainford, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2011
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial
Hagen Kennecke, Scott Berry, Ralph Wong, et al.
JCO Global Oncology
|
June 7, 2022
Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal
Bishal Gyawali, Niresh Thapa, Colleen Savage, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Competency-Based Workforce Development and Education in Global Oncology
Nazik Hammad, Ntokozo Ndlovu, Laura Mae Carson, et al.
The Journal of Ambulatory Care Management
|
August 27, 2019
Chronic Condition Measurement Requires Engagement, Not Measurement Alone
Andrea M Austin, Don Carmichael, Scott Berry, et al.
Plos One
|
October 17, 2015
A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer
Alexander Kumachev, Marie Yan, Scott Berry, et al.
Alzheimer'S Research & Therapy
|
December 9, 2022
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease
Shobha Dhadda, Michio Kanekiyo, David Li, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 146) with videos related to
Sort By:
Page
of 15
Respiratory Research
|
April 8, 2015
Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy
Gillian Stynes, Henrik Svedsater, Jaro Wex, et al.
Asthma Research and Practice
|
December 15, 2016
Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy
Henrik Svedsater, Gillian Stynes, Jaro Wex, et al.
Plos One
|
December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
Donald A Berry, Scott Berry, Peter Hale, et al.
BMC Cancer
|
June 30, 2007
External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer
Christopher M Booth, George Dranitsaris, M Corona Gainford, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2011
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial
Hagen Kennecke, Scott Berry, Ralph Wong, et al.
JCO Global Oncology
|
June 7, 2022
Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal
Bishal Gyawali, Niresh Thapa, Colleen Savage, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Competency-Based Workforce Development and Education in Global Oncology
Nazik Hammad, Ntokozo Ndlovu, Laura Mae Carson, et al.
The Journal of Ambulatory Care Management
|
August 27, 2019
Chronic Condition Measurement Requires Engagement, Not Measurement Alone
Andrea M Austin, Don Carmichael, Scott Berry, et al.
Plos One
|
October 17, 2015
A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer
Alexander Kumachev, Marie Yan, Scott Berry, et al.
Alzheimer'S Research & Therapy
|
December 9, 2022
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease
Shobha Dhadda, Michio Kanekiyo, David Li, et al.
Page
of 15